<form id="ztznx"></form>

      <address id="ztznx"><form id="ztznx"><th id="ztznx"></th></form></address>

        <address id="ztznx"></address>

        尊龙凯时人生就是博·「中国」官方网站

        A Comparative Study of Fibronectin and Moist-Exposed Burns O

        作者:Rong Xiang Xu 出版社:KARGER 發行日期:In 2004

        INTRODUCTION
        Worldwide reports regarding the basic science and clinical applications of fibronectin’s (FN) contribution to the healing of trauma and burns wounds have shown that FN can enhance the epithelial healing rate by promoting the adhesion and migration of epithelial cells at the wound site [1-3]. Clinical application of eye drops made of FN in treating burned corneal has obtained satisfactory results. However, we are still years from the widespread use of FN because the extraction and production of FN eye drops are time-consuming, expensive and offer specific preservation challenges. We have used MEBO since 1990 in the treatment of burned cornea and we have achieved satisfactory results in terms of improving corneal nutrition, promoting wound healing, ammeliorating pain, relieving irritation and reducing the incidence of corneal ulceration. Therefore, we embarked on an experimental study to verify the effect of MEBO as compared with FN in the management of corneal burns in rabbits.

        MATERIALS AND METHODS
        MEBO, developed by Beijing Guangming Chinese Medicine Institute for Burns, Wounds and Ulcers, is an ointment containing sesame oil, beeswax and other active ingredients derived from plant such as Cortex Phellodendri and Radix Scutellariae. FN produced by the Shanghai Institute of Biological Products was diluted to a solution containing 400g/ml with sterile normal saline.

        Five healthy New Zealand white rabbit (body weight 2-3 kg) without eye disease were anaesthetized intramuscularly with 20mg/kg sodium thiopental and eye solution of 0.4 % Novesine two drops in each eye. 8-mm filter papers, previously soaked completely in 0.5N NaOH, were laid on the middle of both corneal, respectively. One minute later, the paper was removed and the eyes were rinsed immediately with sterile normal saline. Then eye drops made of FN were administered to the right eyes, four times daily and MEBO was applied on the left eyes, three times daily. Both courses lasted 2 weeks.

        At 6, 24, 36 and 48 h postinjury, the corneal fluorescent staining zones were photographed with a DF Haiou camera (China) at fixed focus. After developing the film, we drew the fluorescent staining zones, analyzed and measured the areas at different h using a computer image pattern analyzer, and then calculated the epithelial healing rate (mm2/hour) by linear regression. Observations were made twice daily on days 3~14 postinjury and fluorescent staining zones were regarded as a positive indicator. Epithelial damage rate = (fluorescent staining positive number) / (number of eyes examined)  100%.

        Besides corneal fluorescent staining zone, conjunctival congestion and corneal transparency were also observed. (1) Conjunctival congestion: + = palpebral conjunctival congestion; ++ = palpebral conjunctival and partial bulbar conjunctival congestion; +++ = whole palpebral and bulbar conjunctival congestion. (2) Corneal transparency: + = slightly opacity with distinct structure of underlying iridial texture; ++ = moderate opacity with blurred structure of iridial texture; +++ = severe corneal opacity with indistinct structure of iridial texture.

        RESULT
        In the early stage (at 6 h postinjury) epithelial healing was slow and at 6 - 48 h the healing rate remained constant The use of FN on eyes shows an epithelial healing rate of 1.2790.317 mm2/h compared to 1.2850.128 mm2/h with the MEBO treatment. There is no significant difference between the two groups although in the MEBO group treatment efficacy is a little faster.

        Repeated corneal damage occurred from the early healing stage until 2 weeks postinjury and there is a significant difference in damage rate in both groups: 58.3 % in the FN group and 33.3 % in the MEBO group (u=5.56, P<0.01).

        The cornea showed disk opacity a few minutes following burn. Conjunctival congestion with white secretion was observed at 3 h postinjury. On day 2 postinjury, eye irritation became obvious with increased secretion and corneal edema was noted until 1 week postinjury when edema was still observed in epithelium and matrix. At 2 weeks postinjury, the above symptoms were further relieved. The advantages of MEBO treatment as compared to FN in the management of burns eyes were demonstrated both in terms of corneal epithelial exfoliation and regarding conjunctival congestion and opacity.

        CONCLUSION
        Some advantages of MEBO include inexpensive cost, convenient application, safety and product stability. The effect of MEBO in the treatment of alkali-burned corneas compared favorably to that achieved with FN. MEBO proved more effective than FN in reducing the epithelial damage rate and was far easier to use given a widespread application. We suggest that MEBO treatment is remarkably advantageous in reducing the repeated epithelial damage rate of alkali burns eyes compared to FN treatment.

        DISCUSSION
        It has been reported that FN has the effect of promoting epithelial healing rate on corneal defects [4]. This study verified no significant difference in promoting corneal epithelial healing between the two groups. However, MEBO treatment is remarkably advantageous in reducing the repeated epithelial damage rate of alkali burns eyes compared to FN treatment. The repair of relative integrity of the corneal epithelium is beneficial to the stability of corneal parenchyma and endothelium. The cornea in the MEBO group showed slight transparency with slight congestion. Subsequent to alkali burns, the integrity of basement membrane underlying corneal epithelium was damaged. The appropriate replacement of exogenous FN may reduce the possibility of epithelium damage, as FN is needed for repair of basement membrane. This study demonstrated that MEBO is superior to FN with regard to firm adherence of corneal epithelium and maintenance and basement membrane integrity. In addition, MEBO supplies rich nutrients necessary for repairing and regeneration of alkali burns corneas.

        FN is a kind of macromolecular glucoprotein which operates at the wound surface. The surge of enzymes released subsequent to alkali burn causes the degradation of FN at the wound surface. The paucity of FN resulting from enzymatic degradation can be compensated with exogenous FN, which reduces the epithelial damage rate by promoting epithelium adhesion. Many combining sites in FN molecular structure served as a bridge between epithelial cells and basement membrane, thereby improving epithelium adhesion. Affinity between FN and intracellular actin may cause the change of epithelial intracellular actin from sphere to fibriform and then induce cell migration.

        As avascular tissue, the cornea receives the nutrition and oxygen necessary for metabolism mainly from diffusion of the vascular net in the corneal limbus, from tears and from aqueous humor. Glucose is the main source of energy for oxygenic metabolism of corneal epithelium and for intraparenchymatous anaerobic metabolism [5]. MEBO contains abundant glucose, organic acid, a variety of vitamins, proteins and enzymes as well, all of which directly provide energy and nutrition for alkali-burned corneal tissue. In this manner, MEBO serves to promote metabolism of the corneal, to accelerate the prompt removal of necrotic tissue and to facilitate swift growth of new epithelium. MEBO also has anti-inflammatory properties, bacterial inhibition, repercussive and analgesic effects [6]. By relieving local congestion and corneal irritation, blepharospasm due to pains and nictitation were alleviated, which reduced the friction to corneal surface and also improved local resistance.

        REFERENCES
        1. Fujikawa LS, Foster CS, Harrist TJ, Lanigan JM, Colvin RB, et al: Fibronectin in healing rabbit corneal wounds. Lab Invest 1981; 45: 120-129.
        2. Nishida T, Nakagawa S, Awata T, Nishibayashi C, Manabe R: Rapid preparation of purified autologous fibronectin eyedrops from patient’s plasma.. Jpn J Ophthalmol 1982; 26: 410.
        3. Shi SM, et al: Comparative physical properties of ophthalmic viscoelastic materials. J Pract Ophthalmol 1989; 7: 9.
        4. Nishida T, et al: Fibronectin enhancement of corneal epithelial wound healing of rabbits in vivo. Arch Opnthalmol 1984; 102: 455.
        5. Liu JQ, et al (eds): Practical ophthalmology. Beijing, People’s Health Press, 1984, p43.
        6. Xu RX: The medicine of burn and ulcer: A general introduction. Chin J Burns Wounds  Surface Ulcers 1989; 1: 11.

        關于尊龙凯时人生就是博
        尊龙凯时人生就是博簡介
        尊龙凯时人生就是博營銷
        尊龙凯时人生就是博大事件
        尊龙凯时人生就是博
        新聞中心
        最新動態
        媒體報道
        視頻中心
        學術動態
        視頻中心
        國際活動
        新聞報道
        企業文化
        再生生命科學
        臨床應用
        科學大事記
        學術網絡
        專家團隊
        企業責任
        企業價值
        公益組織
        善行天下
        國際發展
        國際平臺
        國際研究基地
         
        尊龙凯时人生就是博醫藥科技集團有限公司(尊龙凯时人生就是博集團)旗下公司含:北京尊龙凯时人生就是博高科技有限責任公司,廊坊尊龙凯时人生就是博制藥有限責任公司、上海尊龙凯时人生就是博生命科技有限公司。涉及藥品、化妝品、保健品、食品、消毒產品、醫療器械產品均由以上三家公司生產。尊龙凯时人生就是博集團官網展示宣傳。
        尊龙凯时人生就是博集團旗下:MEBO尊龙凯时人生就是博集團商城 | 尊龙凯时人生就是博全球購 | GLYMATE商城
        技術支持:尚品中國Copyright ? 尊龙凯时人生就是博集團 版權所有 京ICP備32848851號-1 京公網安備110105001616
        友情鏈接:百度一下 搜索 360搜索 網站首頁
        尊龙凯时人生就是博
      1. 日韩激情电影在线观看